The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells.
Ontology highlight
ABSTRACT: Luminal A and B breast cancers are the most prevalent forms of breast cancer diagnosed in women. Compared to luminal A breast cancer patients, patients with luminal B breast cancers experience increased disease recurrence and lower overall survival. The mechanisms that regulate the luminal B subtype remain poorly understood. The chemokine CCL2 is overexpressed in breast cancer, correlating with poor patient prognosis. The purpose of this study was to determine the role of CCL2 expression in luminal B breast cancer cells. Breast tissues, MMTV-PyVmT and MMTV-Neu transgenic mammary tumors forming luminal B-like lesions, were immunostained for CCL2 expression. To determine the role of CCL2 in breast cancer cells, CCL2 gene expression was silenced in mammary tumor tissues and cells using TAT ce
SUBMITTER: Fang WB
PROVIDER: S-EPMC4456035 | biostudies-literature | 2015 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA